<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7256539\results\search\disease\results.xml">
  <result pre="doi: 10.1016/j.mayocp.2020.05.013 : Article Sex Hormones and Novel Corona Virus" exact="Infectious" post="Disease (COVID-19) Al-LamiRasha A.MDraallami@utmb.eduaâˆ—UrbanRandall J.MDbVolpiElenaMD, PhDbAlgburiAmmar M.A.MDcBaillargeonJacquesPhDa[a], [b], [c],"/>
  <result pre="10.1016/j.mayocp.2020.05.013 : Article Sex Hormones and Novel Corona Virus Infectious" exact="Disease" post="(COVID-19) Al-LamiRasha A.MDraallami@utmb.eduaâˆ—UrbanRandall J.MDbVolpiElenaMD, PhDbAlgburiAmmar M.A.MDcBaillargeonJacquesPhDa[a], [b], [c], âˆ—Correspondence:"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="remains active. Abstract Given the rapid spread of the coronavirus" exact="disease" post="2019 (COVID-19) pandemic and its overwhelming effect on health"/>
  <result pre="global economy, innovative therapeutic strategies are urgently needed. The proposed" exact="primary" post="culprit of COVID-19 is the intense inflammatory responseâ€&quot;an augmented"/>
  <result pre="and women with COVID-19. Abbreviations and Acronyms ACE2, angiotensin-converting enzyme" exact="type 2" post="Ang II, angiotensin II AT1R, type 1 angiotensin receptor"/>
  <result pre="ACE2, angiotensin-converting enzyme type 2 Ang II, angiotensin II AT1R," exact="type 1" post="angiotensin receptor COVID-19, coronavirus disease 2019 IL-1/6/8, interleukin-1/6/8 NF-ÎºB,"/>
  <result pre="II, angiotensin II AT1R, type 1 angiotensin receptor COVID-19, coronavirus" exact="disease" post="2019 IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe"/>
  <result pre="disease 2019 IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe" exact="acute" post="respiratory syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î±"/>
  <result pre="2019 IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe acute" exact="respiratory" post="syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î± Severe"/>
  <result pre="IL-1/6/8, interleukin-1/6/8 NF-ÎºB, nuclear factor ÎºB SARS-CoV-2, severe acute respiratory" exact="syndrome" post="coronavirus 2 TNF-Î±, tumor necrosis factor Î± Severe acute"/>
  <result pre="factor ÎºB SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 TNF-Î±," exact="tumor" post="necrosis factor Î± Severe acute respiratory syndrome coronavirus 2"/>
  <result pre="acute respiratory syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î±" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rapidly"/>
  <result pre="respiratory syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î± Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to rapidly spread"/>
  <result pre="syndrome coronavirus 2 TNF-Î±, tumor necrosis factor Î± Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) continues to rapidly spread worldwide."/>
  <result pre="coronavirus 2 TNF-Î±, tumor necrosis factor Î± Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) continues to rapidly spread worldwide. To"/>
  <result pre="To date, no specific therapeutic agents or vaccines for coronavirus" exact="disease" post="2019 (COVID-19) are available, and much information on the"/>
  <result pre="protective effect of younger age occurs in both male and" exact="female" post="patients.1, 2, 3 As we search for treatment strategies"/>
  <result pre="rates holds broad clinical and public health relevance. For most" exact="infectious diseases," post="women have been consistently observed to mount a stronger"/>
  <result pre="a stronger immune response than do men.4 In general, the" exact="female" post="immune system responds more efficiently to pathogens, producing higher"/>
  <result pre="in both the 2003 SARS-CoV and the 2012 Middle East" exact="respiratory" post="syndrome epidemics, women have substantially lower case-fatality rates than"/>
  <result pre="both the 2003 SARS-CoV and the 2012 Middle East respiratory" exact="syndrome" post="epidemics, women have substantially lower case-fatality rates than do"/>
  <result pre="the 2012 Middle East respiratory syndrome epidemics, women have substantially" exact="lower" post="case-fatality rates than do men.6 Among the theoretical pathways"/>
  <result pre="COVID-19. Briefly, SARS-CoV-2 enters the cell via the angiotensin-converting enzyme" exact="type 2" post="(ACE-2) receptor, which is expressed by pneumocytes, and leads"/>
  <result pre="and leads to the down-regulation of ACE-2 levels. Angiotensin-converting enzyme" exact="type 2" post="is normally responsible for converting angiotensin II (Ang II)"/>
  <result pre="and less immune augmenting variants of angiotensin. Angiotensin II binds" exact="type 1" post="angiotensin receptors (AT1Rs) in the lung to induce vasoconstriction"/>
  <result pre="ACE-2 and high levels of Ang II lead to increased" exact="pulmonary" post="vessel permeability, which subsequently results in inflammatory damage to"/>
  <result pre="results in inflammatory damage to the lung tissue.10 The proposed" exact="primary" post="culprit of severe COVID-19 is the cytokine storm resulting"/>
  <result pre="levels and low T-lymphocyte levels were predictive of high pharyngeal" exact="viral" post="loads and increased mortality.12 These findings are consistent with"/>
  <result pre="response resulting in the circulation of tissue-damaging cytokines is the" exact="primary" post="mediator in pulmonary viral infection.11 It is also possible"/>
  <result pre="the circulation of tissue-damaging cytokines is the primary mediator in" exact="pulmonary" post="viral infection.11 It is also possible that SARS-CoV-2 directly"/>
  <result pre="circulation of tissue-damaging cytokines is the primary mediator in pulmonary" exact="viral" post="infection.11 It is also possible that SARS-CoV-2 directly activates"/>
  <result pre="SARS-CoV-2 directly activates mast cells, which are found in the" exact="respiratory" post="tract submucosa, with the subsequent release of proinflammatory cytokines"/>
  <result pre="levels in premenopausal women.5,15 Most cytokines, namely, IL-6, IL-8, and" exact="tumor" post="necrosis factor Î± (TNF-Î±), are inhibited by periovulatory dosages"/>
  <result pre="proinflammatory states that most postmenopausal women suffer from (eg, atherosclerosis).5" exact="Postmenopausal" post="women are reported to have higher levels of proinflammatory"/>
  <result pre="have been found to enhance cellular immunity in HIV-infected patients.16" exact="Female" post="mice receiving high levels of estrogen are reported to"/>
  <result pre="levels of estrogen are reported to have increased survival and" exact="lower" post="cytokine production in the lung after influenza infection.4 Likewise,"/>
  <result pre="activates the NF-ÎºB pathway to increase cytokine synthesis after SARS" exact="infection" post="while estrogen can shut down the NF-ÎºB pathway holds"/>
  <result pre="NF-ÎºB pathway holds possible relevance for COVID-19 treatment strategies in" exact="female" post="patients. Estrogenâ€™s anti-inflammatory effect against coronaviruses is supported by"/>
  <result pre="by several animal studies.18 First, researchers who infected male and" exact="female" post="mice with SARS-CoV reported that male mice had a"/>
  <result pre="reported that male mice had a worse prognosis than did" exact="female" post="mice. Specifically, after SARS-CoV infection, male mice had higher"/>
  <result pre="female mice. Specifically, after SARS-CoV infection, male mice had higher" exact="viral" post="titers, more pulmonary vascular permeability and/or alveolar edema, and"/>
  <result pre="after SARS-CoV infection, male mice had higher viral titers, more" exact="pulmonary" post="vascular permeability and/or alveolar edema, and more inflammatory monocytes"/>
  <result pre="SARS-CoV infection, male mice had higher viral titers, more pulmonary" exact="vascular" post="permeability and/or alveolar edema, and more inflammatory monocytes and"/>
  <result pre="inflammatory monocytes and macrophages in their lungs than did age-matched" exact="female" post="mice.18 Second, SARS-CoVâ€&quot;infected female mice that were estrogen depleted"/>
  <result pre="in their lungs than did age-matched female mice.18 Second, SARS-CoVâ€&quot;infected" exact="female" post="mice that were estrogen depleted by oophorectomy or estrogen"/>
  <result pre="protective role against SARS-CoV-2. Although women have accounted for a" exact="lower" post="number of COVID-19 cases than do men,20 it is"/>
  <result pre="and humoral immune systems. In fact, testosterone was found to" exact="lower" post="IL-6 and TNF-Î± levels via inhibition of the NF-ÎºB"/>
  <result pre="of the NF-ÎºB proinflammatory pathway, analogous to estrogen.21 Moreover, testosterone" exact="deficiency" post="has been linked with autoimmune disease and increases in"/>
  <result pre="analogous to estrogen.21 Moreover, testosterone deficiency has been linked with" exact="autoimmune disease" post="and increases in inflammatory markers, such as C-reactive protein.22,23"/>
  <result pre="to estrogen.21 Moreover, testosterone deficiency has been linked with autoimmune" exact="disease" post="and increases in inflammatory markers, such as C-reactive protein.22,23"/>
  <result pre="the need for assisted ventilation through its anticatabolic effect on" exact="respiratory" post="muscles.27 A recent study found that hypogonadism was common"/>
  <result pre="anticatabolic effect on respiratory muscles.27 A recent study found that" exact="hypogonadism" post="was common in mechanically ventilated patients with acute respiratory"/>
  <result pre="found that hypogonadism was common in mechanically ventilated patients with" exact="acute" post="respiratory failure and was strongly associated with longer intensive"/>
  <result pre="that hypogonadism was common in mechanically ventilated patients with acute" exact="respiratory" post="failure and was strongly associated with longer intensive care"/>
  <result pre="that testosterone therapy may improve outcomes in hospitalized patients with" exact="chronic" post="obstructive pulmonary disease.29 Further research is needed on this"/>
  <result pre="therapy may improve outcomes in hospitalized patients with chronic obstructive" exact="pulmonary" post="disease.29 Further research is needed on this potential effect."/>
  <result pre="extra X chromosome, have stronger immune function and more efficient" exact="viral" post="clearingâ€&quot;these factors might not explain the dramatic within-sex case-fatality"/>
  <result pre="rates of smoking, which increases vulnerability of lung tissues to" exact="viral infection" post="and other lifestyle factors, which increase their rates of"/>
  <result pre="of smoking, which increases vulnerability of lung tissues to viral" exact="infection" post="and other lifestyle factors, which increase their rates of"/>
  <result pre="and other lifestyle factors, which increase their rates of underlying" exact="cardiovascular disease" post="and diabetes.31 Second, it is important to acknowledge that"/>
  <result pre="other lifestyle factors, which increase their rates of underlying cardiovascular" exact="disease" post="and diabetes.31 Second, it is important to acknowledge that"/>
  <result pre="and women, may be partly attributable to concurrent morbidities, especially" exact="cardiovascular" post="diseases and diabetes. In addition, there is concern that"/>
  <result pre="particularly older adults and those with hormone deficiencies. Assessing the" exact="disease" post="progression and outcomes of such patients, with particular attention"/>
  <result pre="References References 1WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
  <result pre="a report of 72314 cases from the Chinese Center for" exact="Disease" post="Control and PreventionJAMA32313202012391242 2RichardsonS.HirschJ.S.NarasimhanM.Presenting characteristics, comorbidities, and outcomes among"/>
  <result pre="hospitalized with COVID-19 in the New York City areaJAMA32320202020522059 3LivingstonE.BucherK.Coronavirus" exact="disease" post="2019 (COVID-19) in Italy [published online ahead of print"/>
  <result pre="6KarlbergJ.ChongD.S.Y.LaiW.Y.Y.Do men have a higher case fatality rate of severe" exact="acute" post="respiratory syndrome than women do?Am J Epidemiol1593200422923114742282 7WadmanM.Couzin-FrankelJ.KaiserJ.MatacicC.How does"/>
  <result pre="men have a higher case fatality rate of severe acute" exact="respiratory" post="syndrome than women do?Am J Epidemiol1593200422923114742282 7WadmanM.Couzin-FrankelJ.KaiserJ.MatacicC.How does coronavirus"/>
  <result pre="have a higher case fatality rate of severe acute respiratory" exact="syndrome" post="than women do?Am J Epidemiol1593200422923114742282 7WadmanM.Couzin-FrankelJ.KaiserJ.MatacicC.How does coronavirus kill?"/>
  <result pre="kill? Clinicians trace a ferocious rampage through the body, from" exact="brain" post="to toes. Science. American Association for the Advancement of"/>
  <result pre="ferocious rampage through the body, from brain to toes. Science." exact="American" post="Association for the Advancement of Science websitehttps://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes#Published April 17,"/>
  <result pre="8, 2020 8ContiP.RonconiG.CaraffaA.Induction of pro-inflammatory cytokines (IL-1 and IL-6) and" exact="lung inflammation" post="by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategiesJÂ Biol Regul"/>
  <result pre="outcome of human influenza A (H5N1) is associated with high" exact="viral" post="load and hypercytokinemiaNat Med121020061203120716964257 13KritasS.K.RonconiG.CaraffaA.GallengaC.E.RossR.ContiP.Mast cells contribute to coronavirus-induced"/>
  <result pre="Regul Homeost Agents3412020 14Giefing-KrÃ¶llC.BergerP.LepperdingerG.Grubeck-LoebensteinB.How sex and age affect immune responses," exact="susceptibility to" post="infections, and response to vaccinationAging Cell143201530932125720438 15GaskinsA.J.WilcheskyM.MumfordS.L.Endogenous reproductive hormones"/>
  <result pre="16HelZ.StringerE.MesteckyJ.Sex steroid hormones, hormonal contraception, and the immunobiology of human" exact="immunodeficiency" post="virus-1 infectionEndocr Rev3112010799719903932 17BiswasD.K.SinghS.ShiQ.PardeeA.B.IglehartJ.D.Crossroads of estrogen receptor and NF-ÎºB"/>
  <result pre="estrogen receptor and NF-ÎºB signalingSci STKE20052882005pe2715956359 18ChannappanavarR.FettC.MackM.Ten EyckP.P.MeyerholzD.K.PerlmanS.Sex-based differences in" exact="susceptibility to" post="severe acute respiratory syndrome coronavirus infectionJÂ Immunol1981020174046405328373583 19LuR.ZhaoX.LiJ.Genomic characterisation"/>
  <result pre="NF-ÎºB signalingSci STKE20052882005pe2715956359 18ChannappanavarR.FettC.MackM.Ten EyckP.P.MeyerholzD.K.PerlmanS.Sex-based differences in susceptibility to severe" exact="acute" post="respiratory syndrome coronavirus infectionJÂ Immunol1981020174046405328373583 19LuR.ZhaoX.LiJ.Genomic characterisation and epidemiology"/>
  <result pre="signalingSci STKE20052882005pe2715956359 18ChannappanavarR.FettC.MackM.Ten EyckP.P.MeyerholzD.K.PerlmanS.Sex-based differences in susceptibility to severe acute" exact="respiratory" post="syndrome coronavirus infectionJÂ Immunol1981020174046405328373583 19LuR.ZhaoX.LiJ.Genomic characterisation and epidemiology of"/>
  <result pre="STKE20052882005pe2715956359 18ChannappanavarR.FettC.MackM.Ten EyckP.P.MeyerholzD.K.PerlmanS.Sex-based differences in susceptibility to severe acute respiratory" exact="syndrome" post="coronavirus infectionJÂ Immunol1981020174046405328373583 19LuR.ZhaoX.LiJ.Genomic characterisation and epidemiology of 2019"/>
  <result pre="novel coronavirus: implications for virus origins and receptor bindingLancet39510224202056557432007145 20Coronavirus" exact="Disease" post="2019 (COVID-19): daily data summary. NYC health websitehttps://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-daily-data-summary-hospitalizations-04032020-1.pdf 21TraishA.BolanosJ.NairS.SaadF.MorgentalerA.Do"/>
  <result pre="biomarkers in US menAndrology16201391992824124163 23BaillargeonJ.Al SnihS.RajiM.A.Hypogonadism and the risk of" exact="rheumatic" post="autoimmune diseaseClin Rheumatol351220162983298727325124 24LiH.ManwaniB.LengS.X.Frailty, inflammation, and immunityAging Dis26201146647322396895 25MorleyJ.E.KimM.J.HarenM.T.Frailty"/>
  <result pre="in US menAndrology16201391992824124163 23BaillargeonJ.Al SnihS.RajiM.A.Hypogonadism and the risk of rheumatic" exact="autoimmune" post="diseaseClin Rheumatol351220162983298727325124 24LiH.ManwaniB.LengS.X.Frailty, inflammation, and immunityAging Dis26201146647322396895 25MorleyJ.E.KimM.J.HarenM.T.Frailty and"/>
  <result pre="Disord62200510110815843881 26StoccoC.Tissue physiology and pathology of aromataseSteroids771-22012273522108547 27DillonE.L.DurhamW.J.UrbanR.J.Sheffield-MooreM.Hormone treatment and" exact="muscle" post="anabolism during aging: androgensClin Nutr296201069770020452103 28AlmoosaK.F.GuptaA.PedrozaC.WattsN.B.Low testosterone levels are"/>
  <result pre="androgensClin Nutr296201069770020452103 28AlmoosaK.F.GuptaA.PedrozaC.WattsN.B.Low testosterone levels are frequent in patients with" exact="acute" post="respiratory failure and are associated with poor outcomesEndocr Pract201020141057106324936547"/>
  <result pre="Nutr296201069770020452103 28AlmoosaK.F.GuptaA.PedrozaC.WattsN.B.Low testosterone levels are frequent in patients with acute" exact="respiratory" post="failure and are associated with poor outcomesEndocr Pract201020141057106324936547 29BaillargeonJ.UrbanR.J.ZhangW.Testosterone"/>
  <result pre="30ContiP.YounesA.Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to" exact="viral" post="infectionJÂ Biol Regul Homeost Agents3422020 31CaiH.Sex difference and smoking"/>
  <result pre="predisposition in patients with COVID-19Lancet Respir Med842020e2032171067 32FangL.KarakiulakisG.RothM.Are patients with" exact="hypertension" post="and diabetes mellitus at increased risk for COVID-19 infection?Lancet"/>
  <result pre="patients with COVID-19Lancet Respir Med842020e2032171067 32FangL.KarakiulakisG.RothM.Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection?Lancet Respir Med842020e2132171062 33SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic"/>
  <result pre="risk for COVID-19 infection?Lancet Respir Med842020e2132171062 33SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for coronavirus" exact="disease" post="2019 (COVID-19): a review [published online ahead of print"/>
  <result pre="34ContiP.GallengaC.E.TeteG.How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2)" exact="infection" post="and lung inflammation mediated by IL-1JÂ Biol Regul Homeost"/>
  <result pre="reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and" exact="lung inflammation" post="mediated by IL-1JÂ Biol Regul Homeost Agents3422020 Supplemental Online"/>
 </snippets>
</snippetsTree>
